Latest News about JAZZ
Recent news which mentions JAZZ
FDA says it will not regulate CBD and calls on Congress to act
January 26, 2023
Tickers
JAZZ
Tags
JAZZ
From MarketWatch
2 Promising New Growth Stocks to Watch in 2023
January 23, 2023
From Motley Fool
Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer
January 19, 2023
From Benzinga
From Motley Fool
From Motley Fool
Will Investors Notice Exciting Sign On Jazz Pharmaceuticals's Chart?
January 06, 2023
Tickers
JAZZ
From Benzinga
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
January 05, 2023
From Benzinga
2 Cannabis Stocks to Buy for the Long Haul
December 31, 2022
From Motley Fool
2 Growth Stocks to Buy Heading Into 2023
December 30, 2022
From Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
From Motley Fool
Better Buy: Moderna vs Axsome
December 22, 2022
From Motley Fool
Tesla, Amazon, Micron, Sintx, Zymeworks: Why These 5 Stocks Are Drawing Investors' Attention Today
December 21, 2022
From Benzinga
Jazz Pharma Opts In, Advances Zanidatamab Partnership With Zymeworks
December 21, 2022
From Benzinga
After Jumping 100%, Is Axsome a Buy Before 2023?
December 16, 2022
From Motley Fool
From Benzinga
What 6 Analyst Ratings Have To Say About Jazz Pharmaceuticals
December 09, 2022
Tickers
JAZZ
From Benzinga
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
December 08, 2022
From Motley Fool
3 Fierce Stocks That Are Screaming Buys in December
December 07, 2022
From Motley Fool
Jazz Caregiver Survey: CBD-Based Epidiolex Improves Seizure & Non-Seizure Outcomes In Patients With Severe Epilepsy
December 05, 2022
Tickers
JAZZ
From Benzinga
Goldman Sachs, Walmart And These 2 Stocks Insiders Are Selling
November 28, 2022
From Benzinga
Want to Double Your Money? Buying These Stocks Could be a Genius Move
November 28, 2022
From Motley Fool
Louis Armstrong Loved Cannabis And Didn't Care Who Knew It, New Documentary Looks At Jazz Legend's Life And Art
November 25, 2022
From Benzinga
Prediction: This Growth Stock Could Double in 2023
November 24, 2022
From Motley Fool
Analyst Bumps Up Price Target For Avadel Pharmaceuticals After Favorable Patent Ruling
November 21, 2022
From Benzinga
Avadel Pharmaceuticals Announces Favorable Ruling Regarding Sleep Disorder Drug Patent
November 21, 2022
From Benzinga
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
November 20, 2022
From Motley Fool
3 Top Cannabis Stocks to Buy in November
November 20, 2022
From Motley Fool
2 Dirt Cheap Growth Stocks to Buy and Hold for Years
November 18, 2022
From Motley Fool
Is Axsome Therapeutics Stock a Buy Now?
November 11, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.